Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Capital Expenditures (2014 - 2015)

Updated

Oncotelic Therapeutics (OTLC) recorded Capital Expenditures of -$1,000 in Q4 2015, compared with $11,000 a year earlier.

Analysis

Oncotelic Therapeutics (OTLC) Capital Expenditures (2014 - 2015) Analysis & Trends

For FY2015, Oncotelic Therapeutics reported Capital Expenditures of $13,000, down 23.5% from FY2014.

  • Annual Capital Expenditures has a three-year compound annual growth rate of 17.6% (FY2012 to FY2015).
  • Across earlier years, Capital Expenditures came in at $17,000 in FY2014 (-51.4%), $35,000 in FY2013 (+337.5%) and $8,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 1.32 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 322.00 Mn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 140.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 533.00 Mn
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -1,000.00
Sep 30, 2015 -1,000.00
Dec 31, 2014 11,000.00
API Access

Oncotelic Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=OTLC&period=max&api_key=YOUR_API_KEY